Company Filing History:
3 out of 647 
2 out of 1,153 
2 out of 3,539 
Years Active: 2020-2025
Title: Ross P. Holmes: Innovator in Hyperoxaluria Treatment
Introduction
Ross P. Holmes is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of medicine, particularly in the treatment of hyperoxaluria. With a total of 3 patents to his name, Holmes has focused on developing innovative solutions to address this medical condition.
Latest Patents
Holmes' latest patents include methods for treating primary or idiopathic hyperoxaluria using small molecule inhibitors of lactate dehydrogenase. The disclosure outlines methods for administering a therapeutically effective amount of specific compounds to patients suffering from this condition. These compounds are designed to inhibit the conversion of glyoxylate to oxalate, thereby preventing or significantly reducing the buildup of oxalate in the kidneys, bladder, urinary tract, and other parts of the body. This innovative approach is particularly beneficial for patients with elevated oxalate levels associated with various types of hyperoxaluria.
Career Highlights
Throughout his career, Ross P. Holmes has worked with esteemed organizations such as the UAB Research Foundation and Vanderbilt University. His work in these institutions has allowed him to collaborate with other professionals in the field and contribute to advancements in medical research and treatment.
Collaborations
Holmes has collaborated with notable coworkers, including Matthew E. Hall and Daniel Jason Urban. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Ross P. Holmes is a distinguished inventor whose work in treating hyperoxaluria has the potential to improve the lives of many patients. His innovative patents and collaborations reflect his commitment to advancing medical science and finding effective solutions for complex health issues.